ClinVar Miner

Submissions for variant NM_001110792.2(MECP2):c.434G>A (p.Arg145His) (rs61748389)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000133092 SCV000191036 pathogenic not provided 2016-06-20 criteria provided, single submitter clinical testing The R133H pathogenic variant in the MECP2 gene has been reported previously in individuals with classic and atypical Rett syndrome, (Hoffbuhr, et al., 2001; Philippe et al., 2006), including a female with the preserved speech variant of Rett syndrome (Bao et al., 2008) and in a male with Rett syndrome where R133H was observed as a somatic mosaic pathogenic variant (Armstrong et al., 2011). R133H alters a highly conserved residue in the methyl-binding domain (MBD) of the MECP2 protein, where many missense variants at the same codon (R133C, R133G, R133L, R133P) and nearby codons have been reported (RettBASE; Stenson et al, 2014). Therefore, the presence of R133H is consistent with a diagnosis of a MECP2-related disorder
RettBASE RCV000169945 SCV000188082 uncertain significance Rett syndrome 2013-06-12 no assertion criteria provided curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.